Cigna Group $CI Position Lessened by Natixis Advisors LLC

Natixis Advisors LLC decreased its position in shares of Cigna Group (NYSE:CI) by 13.5% in the third quarter, Holdings Channel.com reports. The firm owned 347,023 shares of the health services provider’s stock after selling 54,003 shares during the period. Natixis Advisors LLC’s holdings in Cigna Group were worth $100,029,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Harbor Capital Advisors Inc. increased its position in Cigna Group by 119.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after purchasing an additional 49 shares during the last quarter. Collier Financial acquired a new stake in shares of Cigna Group during the 3rd quarter valued at about $34,000. Traub Capital Management LLC bought a new stake in shares of Cigna Group in the 2nd quarter valued at approximately $48,000. Twin Peaks Wealth Advisors LLC bought a new stake in shares of Cigna Group in the 2nd quarter valued at approximately $52,000. Finally, CNB Bank increased its holdings in Cigna Group by 479.4% in the third quarter. CNB Bank now owns 197 shares of the health services provider’s stock worth $57,000 after buying an additional 163 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling at Cigna Group

In related news, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. This represents a 6.60% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.70% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on CI. Jefferies Financial Group lifted their target price on shares of Cigna Group from $310.00 to $333.00 and gave the company a “buy” rating in a research note on Monday, February 9th. Weiss Ratings restated a “hold (c-)” rating on shares of Cigna Group in a research note on Monday, December 29th. UBS Group restated a “buy” rating and set a $375.00 price target on shares of Cigna Group in a report on Monday, February 9th. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of Cigna Group in a research note on Wednesday. Finally, Royal Bank Of Canada decreased their price objective on shares of Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a report on Friday, February 6th. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $330.42.

Cigna Group Price Performance

Shares of NYSE:CI opened at $271.50 on Monday. The company has a market cap of $71.55 billion, a price-to-earnings ratio of 12.24, a PEG ratio of 0.94 and a beta of 0.27. The business has a 50 day moving average price of $280.71 and a 200 day moving average price of $283.97. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. During the same period in the previous year, the business posted $6.64 EPS. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Research analysts predict that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be given a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend is Thursday, March 5th. Cigna Group’s payout ratio is presently 28.13%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.